Production (Stage)
Dianthus Therapeutics, Inc.
DNTH
$18.31
-$0.98-5.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 263.23M | 275.24M | 281.12M | 360.71M | 377.04M |
| Total Receivables | 1.00M | 807.00K | 2.68M | 1.68M | 876.00K |
| Inventory | 4.31M | 3.04M | 2.68M | 2.31M | 1.51M |
| Prepaid Expenses | 2.07M | 1.47M | 1.01M | 1.00M | 1.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 392.00K | 355.00K | -- | -- | -- |
| Total Current Assets | 271.00M | 280.90M | 287.49M | 365.69M | 380.93M |
|
|
|||||
| Total Current Assets | 271.00M | 280.90M | 287.49M | 365.69M | 380.93M |
| Net Property, Plant & Equipment | 1.64M | 1.75M | 541.00K | 631.00K | 725.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.64M | 9.63M | 4.74M | 2.64M | 811.00K |
| Total Assets | 348.58M | 374.01M | 354.25M | 368.96M | 382.46M |
|
|
|||||
| Total Accounts Payable | 8.27M | 4.58M | 7.57M | 3.70M | 2.61M |
| Total Accrued Expenses | 7.98M | 13.07M | 7.73M | 5.86M | 5.85M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 226.00K | 320.00K | 311.00K | 377.00K | 400.00K |
| Total Finance Division Other Current Liabilities | 479.00K | 479.00K | 100.00K | 100.00K | 100.00K |
| Total Other Current Liabilities | 479.00K | 479.00K | 100.00K | 100.00K | 100.00K |
| Total Current Liabilities | 16.95M | 18.45M | 15.71M | 10.03M | 8.96M |
|
|
|||||
| Total Current Liabilities | 16.95M | 18.45M | 15.71M | 10.03M | 8.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.17M | 1.17M | -- | 30.00K | 97.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.85M | 1.91M | 640.00K | 682.00K | 719.00K |
| Total Liabilities | 19.97M | 21.53M | 16.35M | 10.74M | 9.78M |
|
|
|||||
| Common Stock & APIC | 532.24M | 526.76M | 483.17M | 479.03M | 475.89M |
| Retained Earnings | -203.90M | -174.39M | -145.95M | -120.78M | -103.17M |
| Treasury Stock & Other | 270.00K | 106.00K | 681.00K | -37.00K | -27.00K |
| Total Common Equity | 328.61M | 352.48M | 337.90M | 358.22M | 372.69M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 328.61M | 352.48M | 337.90M | 358.22M | 372.69M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 328.61M | 352.48M | 337.90M | 358.22M | 372.69M |
|
|
|||||